Immunologic Deficiency Syndromes
📧 Sign up to get email alerts when something new happens for Immunologic Deficiency Syndromes.
Sign up freeTop drugs studied for this disease
-
EMA approval · 2026-06-24EMA Authorised: Privigen (human normal immunoglobulin (IVIg)) — CSL Behring GmbH
Authorised status for Privigen (human normal immunoglobulin IVIg) by CSL Behring GmbH in the EMA; therapeutic areas include various immunolo…
-
EMA approval · 2026-06-05EMA Authorised: HyQvia (human normal immunoglobulin) — Baxalta Innovations GmbH
The EMA has authorised HyQvia (human normal immunoglobulin) from Baxalta Innovations GmbH for use in immunologic deficiency syndromes and re…
-
EMA approval · 2024-01-11EMA Authorised: Flebogamma DIF (previously Flebogammadif) (human normal immunoglobulin) — Instituto Grifols S.A.
EMA authorises Flebogamma DIF (human normal immunoglobulin) for multiple immunological indications including mucocutaneous lymph node syndro…
-
CLINICAL_TRIALS trial_result · 2022-10-28Clinical Trial Update: Study of Immune Globulin Intravenous (Human) GC5107 in Subjects With Primary Humoral Immunodeficiency [Phase 3]
Phase 3 trial investigating GC5107 (immune globulin intravenous) in subjects with primary humoral immunodeficiency completed with results po…
-
EMA approval · 2022-06-27EMA Authorised: Kiovig (human normal immunoglobulin (IVIg)) — Takeda Manufacturing Austria AG
Kiovig (human normal immunoglobulin IVIg) has been authorised by EMA for multiple indications including immune thrombocytopenic purpura, bon…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-07-31Clinical Trial Update: ADA Gene Transfer Into Hematopoietic Stem/Progenitor Cells for the Treatment of ADA-SCID [Phase 2]
Phase 2 clinical trial of ADA gene transfer into hematopoietic stem/progenitor cells for ADA-SCID has been completed with results posted.
-
CLINICAL_TRIALS trial_result · 2017-04-14Clinical Trial Update: Stem Cell Transplant for Immunologic or Histiocytic Disorders [Phase 2]
Phase 2 trial update on stem cell transplantation for immunologic or histiocytic disorders, with completed status and results posted in 2017…
-
CLINICAL_TRIALS trial_result · 2014-08-11Clinical Trial Update: A Clinical Study of Intravenous Immunoglobulin [Phase 3]
Phase 3 clinical trial evaluating intravenous immunoglobulin for immunologic deficiency syndromes has completed.
-
CLINICAL_TRIALS trial_result · 2014-07-31Clinical Trial Update: Effects of Orally Administered Beta-glucan on Leukocyte Function in Humans [NA]
This clinical trial update reports the completion and posting of results for a human study evaluating the effects of orally administered bet…